Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of common stock of Integer Holdings Corporation (NYSE: ITGR) for the period between July 25, 2024, and October 22, 2025, due to alleged misleading statements regarding the company's competitive position and sales performance in the electrophysiology market [1][5]. Group 1: Lawsuit Details - The lawsuit claims that Integer Holdings Corporation overstated its competitive position in the electrophysiology manufacturing market and mischaracterized its EP devices as long-term growth drivers for its cardio and vascular segment [5]. - It is alleged that Integer experienced a deterioration in sales related to two of its EP devices, contradicting its claims of strong visibility into customer demand [5]. - The lawsuit asserts that the positive statements made by the defendants about Integer's business and prospects were materially false and misleading, leading to investor damages when the true details became public [5]. Group 2: Participation Information - Investors who purchased Integer common stock during the class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To join the class action, interested parties can visit the provided link or contact Phillip Kim, Esq. for more information [3][6]. - A lead plaintiff must file a motion with the court by February 9, 2026, to represent other class members in the litigation [1][3].

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of Integer Holdings Corporation common stock during the specified Class Period, indicating potential legal issues surrounding the company's disclosures and performance [1][5]. Group 1: Class Action Details - The class action lawsuit is on behalf of purchasers of Integer common stock between July 25, 2024, and October 22, 2025 [1]. - Investors who purchased Integer common stock during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - Interested parties can join the class action by visiting the provided link or contacting the law firm directly [3][6]. Group 2: Allegations Against Integer Holdings - The lawsuit alleges that Integer overstated its competitive position in the electrophysiology manufacturing market [5]. - It claims that despite Integer's assertions of strong customer demand visibility, the company was experiencing a decline in sales for two of its electrophysiology devices [5]. - The lawsuit further states that Integer mischaracterized its electrophysiology devices as long-term growth drivers for its cardio and vascular segment, leading to misleading positive statements about its business and operations [5].

Core Viewpoint - Integer Holdings Corporation is under investigation for potential violations of federal securities laws, which may impact investors who have suffered losses [1] Group 1 - The Law Offices of Howard G. Smith is leading the investigation on behalf of Integer Holdings Corporation investors [1] - Investors who experienced losses in Integer Holdings Corporation (NYSE: ITGR) are encouraged to contact the law firm regarding potential claims [1]

Core Viewpoint - Integer Holdings Corporation is under investigation for potential violations of federal securities laws, which may have resulted in financial losses for investors [1]. Group 1: Investigation Details - The investigation is being conducted by the Law Offices of Frank R. Cruz on behalf of investors who may have lost money on Integer Holdings Corporation [1]. - The investigation was announced on October 23, 2025, prior to the market opening, indicating a significant event for the company [1].

Core Viewpoint - A shareholder has filed a securities class action lawsuit against Integer Holdings Corporation, alleging misrepresentations regarding the company's market position and overstated demand for its electrophysiology devices during the class period from July 25, 2024, to October 22, 2025 [1][2]. Group 1 - The lawsuit claims that the defendants made false statements about Integer's standing in the growing electrophysiology market [2]. - The class action lawsuit is on behalf of investors who purchased or acquired Integer's common stock during the specified class period [1]. - Interested parties can file to serve as lead plaintiff by February 9, 2026, with no fees or expenses required from shareholders [3]. Group 2 - Bernstein Liebhard LLP, the law firm handling the case, has recovered over $3.5 billion for clients since 1993 and has a strong track record in class action litigation [4].

Core Viewpoint - A class action lawsuit has been filed against Integer Holdings Corporation and its senior executives for securities fraud following a significant drop in stock price due to alleged violations of federal securities laws [2][4]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Southern District of New York, titled West Palm Beach Firefighters' Pension Fund v. Integer Holdings Corporation, et al., No. 1:25-cv-10251 [4]. - Investors have until February 9, 2026, to request to lead the case [4]. Group 2: Company Performance and Allegations - Integer designs and manufactures cardiac rhythm management and cardiovascular products, including electrophysiology devices [5]. - The company allegedly overstated demand for its electrophysiology devices while public assurances contradicted the actual decline in demand and revenue [6][5]. Group 3: Stock Price Impact - On October 23, 2025, Integer lowered its 2025 sales guidance to between $1.840 billion and $1.854 billion, down from $1.850 billion to $1.876 billion, which was below analysts' expectations [7]. - The company projected poor net sales growth of -2% to 2% and organic sales growth of 0% to 4% for 2026, admitting that two of its EP devices had slower than expected adoption [7]. - Following this announcement, Integer's stock price fell by $35.22 per share, a decrease of over 32%, from $109.11 on October 22, 2025, to $73.89 on October 23, 2025 [7].

Core Viewpoint - The Integer Holdings Corporation is facing a class action lawsuit for allegedly making false statements and failing to disclose critical information regarding its competitive position and sales performance in the electrophysiology market, leading to significant stock price declines [3][4]. Company Overview - Integer Holdings operates as a medical device contract development and manufacturing company [2]. Allegations of the Lawsuit - The lawsuit claims that Integer Holdings overstated its competitive position in the electrophysiology manufacturing market [3]. - It is alleged that the company experienced a deterioration in sales for two of its electrophysiology devices, contrary to its claims of strong customer demand [3]. - The company mischaracterized its electrophysiology devices as long-term growth drivers for its Cardio & Vascular segment [3]. Financial Performance and Guidance - On October 23, 2025, Integer Holdings lowered its full-year 2025 sales guidance, which was below analysts' expectations [4]. - The company projected net sales growth of -2% to 2% and organic sales growth of 0% to 4% for the full year of 2026 [4]. - Following the announcement, the stock price of Integer Holdings fell by more than 32% [4]. Lead Plaintiff Process - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased Integer Holdings common stock during the class period to seek appointment as lead plaintiff in the lawsuit [5]. - The lead plaintiff represents the interests of all class members and can select a law firm to litigate the case [5]. Law Firm Background - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder litigation, having recovered over $2.5 billion for investors in 2024 alone [6]. - The firm has been ranked 1 in securing monetary relief for investors in securities class action cases for four out of the last five years [6].

Core Points - A class action has been filed against Integer Holdings Corporation (ITGR) on behalf of investors who acquired its securities between July 25, 2024, and October 22, 2025, alleging misleading information regarding the company's market position and product demand [1][2] - The complaint claims that Integer Holdings overstated the demand for its electrophysiology (EP) devices, while in reality, demand had significantly decreased, contradicting the company's claims of outpacing market growth [2] - On October 23, 2025, Integer revised its full-year 2025 guidance, expecting net sales growth of -2% to 2% and organic sales growth of 0% to 4% for 2026, leading to a stock price drop of over 32% [3] Allegations and Impact - The allegations suggest that Integer Holdings misled investors about the demand for its EP devices, which has been declining rather than growing as claimed [2] - The company's admission of slower market adoption for two of its EP devices has raised concerns about continued demand issues into 2026 [3] - Following the announcement of revised guidance, Integer's stock fell by $35.22 per share, closing at $73.89 on October 23, 2025, indicating a significant loss in investor confidence [3] Legal Proceedings - Shareholders interested in participating in the class action must submit their papers by February 9, 2026, to serve as lead plaintiff, representing the interests of other class members [4] - Shareholders are not required to participate in the case to be eligible for recovery, allowing them to remain absent class members if they choose [4]

Core Viewpoint - Investors with significant losses in Integer Holdings Corporation have until February 9, 2026, to file lead plaintiff applications in a securities class action lawsuit due to alleged failures in disclosing material information during the class period [1][3]. Group 1: Lawsuit Details - The lawsuit is pending in the United States District Court for the Southern District of New York, involving Integer and certain executives accused of violating federal securities laws [3]. - The class period for the lawsuit is defined as between July 25, 2024, and October 22, 2025 [1]. Group 2: Financial Performance - On October 23, 2025, Integer disclosed a lower full-year 2025 sales guidance of $1.840 billion to $1.854 billion, which fell short of analysts' estimates [4]. - The company also projected expected net sales growth of -2% to 2% and organic sales growth of 0% to 4% for the full year of 2026, attributed to slower-than-anticipated market adoption of its products [4]. Group 3: Stock Price Impact - Following the announcement of the lowered sales guidance, Integer's share price dropped by $35.22, or over 32%, from a closing price of $109.11 on October 22, 2025, to $73.89 on October 23, 2025 [5].

Core Viewpoint - Integer Holdings Corporation is facing a class action lawsuit for allegedly making false statements and failing to disclose critical information regarding its competitive position and sales performance in the electrophysiology market [3][4]. Group 1: Class Action Lawsuit Details - The class action lawsuit is titled West Palm Beach Firefighters' Pension Fund v. Integer Holdings Corporation and covers purchasers of Integer Holdings common stock from July 25, 2024, to October 22, 2025 [1]. - Investors have until February 9, 2026, to seek appointment as lead plaintiff in the lawsuit [1][5]. - The lawsuit alleges that Integer Holdings overstated its competitive position and misrepresented the sales performance of its electrophysiology devices [3]. Group 2: Allegations and Financial Impact - The lawsuit claims that Integer Holdings experienced a deterioration in sales for two of its electrophysiology devices, contradicting its claims of strong customer demand [3]. - On October 23, 2025, Integer Holdings lowered its full-year 2025 sales guidance, which was below analysts' expectations, and projected net sales growth of -2% to 2% for 2026 [4]. - Following the announcement, the stock price of Integer Holdings fell by more than 32% [4]. Group 3: Company Background - Integer Holdings operates as a medical device contract development and manufacturing company [2]. - The company is involved in the electrophysiology market, which is experiencing growth, but Integer Holdings' position within this market has been called into question [3].